METHODS OF TREATING DIFFUSE LARGE B CELL LYMPHOMA BASED ON PARTICULAR GENETIC SUBTYPE
US Application 62/981,382
Filed on 2020-02-25
Filed on 2020-02-25
Chimeric Antigen Receptors Containing Glypican 2 Binding Domains
US Application 62/876,483
Filed on 2019-07-19
Filed on 2019-07-19
A VIRAL EXPOSURE SIGNATURE FOR DETECTION OF EARLY STAGE HEPATOCELLULAR CARCINOMA
US Application 62/914,138
Filed on 2019-10-11
Filed on 2019-10-11
PEGYLATED RECOMBINANT IMMUNOTOXINS
US Application 62/935,822
Filed on 2019-11-15
Filed on 2019-11-15
HUMAN IMMUNOGENIC EPITOPES OF H, K, AND E HUMAN ENDOGENOUS RETROVIRUSES (HERVs)
US Application 62/963,856
Filed on 2020-01-21
Filed on 2020-01-21
HUMAN IMMUNOGENIC EPITOPES OF HEMO AND HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVs)
US Application 62/963,872
Filed on 2020-01-21
Filed on 2020-01-21
T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY
US Application 63/075,536
Filed on 2020-09-08
Filed on 2020-09-08
CD206 MODULATORS THEIR USE AND METHODS FOR PREPARATION
US Application 62/950,488
Filed on 2019-12-19
Filed on 2019-12-19
T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITY
US Application 62/883,927
Filed on 2019-08-07
Filed on 2019-08-07
Nucleic Acid Nanoparticles (NANP) As Efficient Tools For Controlled Immunomodulation
US Application 62/789,033
Filed on 2019-01-07
Filed on 2019-01-07